- Home
- / Lotus Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lotus Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
NT$254
2024-10-29
Market Capitalization
NT$66.7 B
2024-10-29
Revenue
NT$20.5 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| TWD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.4B | 9.6B | 10.7B | 12.6B | 14.6B | 17.0B | 18.6B | 20.5B |
| Cost of goods sold | 2.9B | 4.6B | 5.4B | 6.2B | 5.8B | 6.3B | 6.3B | 7.0B |
| Gross profit | 3.6B | 5.0B | 5.3B | 6.4B | 8.9B | 10.7B | 12.4B | 13.6B |
| Gross profit margin, % | 52.3% | 49.7% | 50.9% | 60.5% | 63.3% | 66.5% | 66.5% | |
| Operating expense total | 2.7B | 3.2B | 3.0B | 3.3B | 3.7B | 4.5B | 4.9B | 6.0B |
| Depreciation and amortization | 391.5M | 592.2M | 709.6M | 759.4M | 1.0B | 1.3B | 1.4B | 1.6B |
| EBITDA | 870.1M | 1.8B | 2.4B | 3.1B | 5.2B | 6.3B | 7.4B | 7.6B |
| EBITDA margin, % | 18.8% | 22.0% | 24.7% | 35.2% | 36.9% | 40.1% | 37.2% | |
| EBIT | 480.6M | 1.2B | 1.6B | 2.3B | 4.4B | 5.5B | 6.7B | 5.9B |
| EBIT margin, % | 12.7% | 14.8% | 18.3% | 30.0% | 32.6% | 35.8% | 28.9% | |
| Interest income | 13.5M | 7.9M | 3.8M | 5.3M | 3.5M | 31.5M | 101.4M | 114.5M |
| Interest expense | 320.0M | 350.4M | 333.8M | 296.8M | 382.5M | 557.4M | 570.8M | 894.5M |
| Pre tax profit | 163.7M | 977.0M | 1.3B | 1.9B | 3.9B | 5.1B | 6.4B | 5.7B |
| Income tax expense | 39.6M | 209.8M | 274.6M | 466.6M | 919.5M | 997.3M | 1.3B | 998.1M |
| Net Income | 124.1M | 767.2M | 1.0B | 1.4B | 3.0B | 4.1B | 5.1B | 4.7B |